TY - JOUR
T1 - Cellular consequences of arginine methylation
AU - Lorton, Benjamin M.
AU - Shechter, David
N1 - Funding Information:
We thank all the investigators who contributed work we cited, and those whom we were unable to include due to space limitations. Our work was supported by The SAS Foundation for Cancer Research (HHS-0007-16SF), The American Lung Association (LCD-564723), and NIH Grant R01GM108646 (to D.S.). Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Publisher Copyright:
© 2019, Springer Nature Switzerland AG.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Arginine methylation is a ubiquitous post-translational modification. Three predominant types of arginine-guanidino methylation occur in Eukarya: mono (Rme1/MMA), symmetric (Rme2s/SDMA), and asymmetric (Rme2a/ADMA). Arginine methylation frequently occurs at sites of protein–protein and protein–nucleic acid interactions, providing specificity for binding partners and stabilization of important biological interactions in diverse cellular processes. Each methylarginine isoform—catalyzed by members of the protein arginine methyltransferase family, Type I (PRMT1-4,6,8) and Type II (PRMT5,9)—has unique downstream consequences. Methylarginines are found in ordered domains, domains of low complexity, and in intrinsically disordered regions of proteins—the latter two of which are intimately connected with biological liquid–liquid phase separation. This review highlights discoveries illuminating how arginine methylation affects genome integrity, gene transcription, mRNA splicing and mRNP biology, protein translation and stability, and phase separation. As more proteins and processes are found to be regulated by arginine methylation, its importance for understanding cellular physiology will continue to grow.
AB - Arginine methylation is a ubiquitous post-translational modification. Three predominant types of arginine-guanidino methylation occur in Eukarya: mono (Rme1/MMA), symmetric (Rme2s/SDMA), and asymmetric (Rme2a/ADMA). Arginine methylation frequently occurs at sites of protein–protein and protein–nucleic acid interactions, providing specificity for binding partners and stabilization of important biological interactions in diverse cellular processes. Each methylarginine isoform—catalyzed by members of the protein arginine methyltransferase family, Type I (PRMT1-4,6,8) and Type II (PRMT5,9)—has unique downstream consequences. Methylarginines are found in ordered domains, domains of low complexity, and in intrinsically disordered regions of proteins—the latter two of which are intimately connected with biological liquid–liquid phase separation. This review highlights discoveries illuminating how arginine methylation affects genome integrity, gene transcription, mRNA splicing and mRNP biology, protein translation and stability, and phase separation. As more proteins and processes are found to be regulated by arginine methylation, its importance for understanding cellular physiology will continue to grow.
KW - Crosstalk
KW - Histones
KW - Liquid–liquid phase separation
KW - Protein arginine methyltransferase
KW - Ribonucleoprotein
UR - http://www.scopus.com/inward/record.url?scp=85066021674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066021674&partnerID=8YFLogxK
U2 - 10.1007/s00018-019-03140-2
DO - 10.1007/s00018-019-03140-2
M3 - Review article
C2 - 31101937
AN - SCOPUS:85066021674
SN - 1420-682X
VL - 76
SP - 2933
EP - 2956
JO - Cellular and Molecular Life Sciences
JF - Cellular and Molecular Life Sciences
IS - 15
ER -